Sigma-Aldrich is a brand operating within an American chemical, life science, and biotechnology company owned by the multinational chemical conglomerate Merck Group. From Wikipedia
The potential acquisition aims to bolster Merck's oncology portfolio as it navigates R&D challenges and clinical trial setbacks.
